Back to Results
First PageMeta Content
Pharmacology / Etanercept / Anakinra / Rheumatoid arthritis / Tumor necrosis factor-alpha / Placebo / Amgen / Medicine / Immunosuppressants / Immunology


Open Document

File Size: 1,46 MB

Share Result on Facebook

City

Rockville / /

Company

Immunex Corporation / IgG / /

Currency

pence / /

Event

FDA Phase / /

Facility

American College of Rheumatology / Rockville Pike / /

IndustryTerm

proposed introductory advertising / Final printed advertising / /

MedicalCondition

tumor necrosis factor receptor / disease / polyarticular-course juvenile rheumatoid arthritis / inflammatory processes / ankylosing spondylitis / RA psoriatic arthritis / arthritis / rheumatoid arthritis / Serious infections / inflammatory drug / RA disease / tumor necrosis factor / normal inflammatory and immune responses / inflammation / /

Organization

office of Therapeutics Page / Therapeutic Biological Internal Medicine Products Office / Food and Drug Administration / Ph. Director Division / ID SC / Division of Drug Marketing / Advertising and Communication / New Drugs Center for Drug Evaluation and Research Enclosure / American College of Rheumatology / Center for Drug Evaluation and Research / DEPARTMENT OF HEALTH / Center for Biologics Evaluation and Research / ID After administration / /

Person

Marc K. Walton / Douglas Hunt / /

Position

Director / Amgen Regulatory Affairs One Amgen Center Drive Mail Stop 24Thousand Oaks / Physician global assessment / CLINICAL PHARMACOLOGY General / /

Product

SC / ENBREL / sulfasalazine / MTX tablets / Bacteriostatic Water for Injection / prednisone / azathioprine / mannitol / Etanercept / /

ProvinceOrState

Maryland / California / /

Technology

alpha / Pharmacokinetics / http / recombinant DNA technology / PDF / /

SocialTag